IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Vaishali Pharma IPO is a Book Building listing on NSE EMERGE exchange, with an ipo size of ₹ 14.23 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Vaishali Pharma IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd June 2017.
Vaishali Pharma IPO posted revenues of ₹ 66.05 Cr. and PAT of ₹ 0.66 Cr. in FY00 on annualised basis.
Revenue:
₹ 66.05 Cr.
EBITDA Margin:
6.63
% 
Net Worth: ₹ 3.87 Cr.
Market Capitalisation:
[●]
P/E:
72.00 times
P/BV: [●]
EV/EBITDA: 4.59 times
Financial results of Vaishali Pharma IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY17 | FY16 | FY15 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 44.65 | 49.41 | 45.80 | ||
| Net Worth | 3.87 | 3.20 | 3.24 | ||
| Total Debt | 21.17 | 19.76 | 24.04 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
66.05 | 66.71 | 94.56 | ||
EBITDA
EBITDA on annualised basis |
4.38 | 3.73 | 3.97 | ||
PAT
PAT on annualised basis |
0.66 | -0.03 | 0.16 | ||
Vaishali Pharma IPO PAT Margin is 1.00 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Vaishali Pharma IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY17 | FY16 | FY15 |
|---|---|---|---|
| EBITDA Margin (%) | 6.63 | 5.59 | 4.20 |
| PAT Margin (%) | 1.00 | -0.04 | 0.17 |
| EPS (₹) | 2.21 | -0.10 | 0.54 |
| ROE (%) | 17.05 | -0.94 | 4.94 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 1.48 | -0.06 | 0.35 |
| Debt to Equity | 5.47 | 6.18 | 7.42 |
The market Capitalisation of Vaishali Pharma IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Vaishali Pharma IPO prospectus highlights an Return on Equity (ROE) of 17.05 % , Return on Assets (ROA) of 1.48 %, and an EBITDA Margin of 6.63 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Vaishali Pharma IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Vaishali Pharma IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Vaishali Pharma IPO has a Price-to-Earnings (PE) ratio of 72.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Vaishali Pharma IPO reported revenue of ₹ 67.11 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Vaishali Pharma IPO provide insights into sales growth, market demand, and business scalability.
Vaishali Pharma recorded an EBITDA of ₹ 4.38 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Vaishali Pharma Profit After Tax (PAT) is ₹ 0.66 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 66.05 Cr.
EBITDA Margin:
6.63
%
Net Worth: ₹ 3.87 Cr.
Market Capitalisation:
[●]
P/E:
72.00 times
P/BV: [●]
EV/EBITDA:
[●]
Vaishali Pharma operates in Pharmaceutical and Company Dealing In Pharmaceutical Formulations. The Issue is listed on NSE EMERGE in Aug, 2017. Vaishali Pharma IPO size was 14.23 with Issue price of 72.00 .
Merchant Banker(s) of Vaishali Pharma IPO: Pantomath Capital Advisors Private Limited
Vaishali Pharma IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vaishali Pharma IPO listed at a listing price of 70.35 against the offer price of 72.00.
The current market price of Vaishali Pharma is 12.77.
Why Us?
